✦ LIBER ✦

Intercalated chemotherapy and erlotinib: a viable first-line option for patients with advanced NSCLC? – Authors' reply

✍ Scribed by Mok, Tony S K; Wu, Yi-Long

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intercalated chemotherapy and erlotinib:

✍ Zheng, Yulong; Xu, Nong; Zhou, Jianying 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 38 KB

Intercalated combination of chemotherapy

✍ Wu, Yi-Long; Lee, Jin Soo; Thongprasert, Sumitra; Yu, Chong-Jen; Zhang, Li; Ladr 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 586 KB

First-line erlotinib in patients with ad

✍ Siow Ming Lee; Iftekhar Khan; Sunil Upadhyay; Conrad Lewanski; Stephen Falk; Ger 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 314 KB

A phase II study of carboplatin and pacl

✍ Giorgio, Carmelo Giannitto; Pappalardo, Alessandro; Russo, Antonio; Giuffrida, D 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 95 KB

614 The proteomic classifier VeriStrat®

✍ E. Smit; H. Roder; J. Grigorieva; J. Roder; J. Lind; A. Dingemans; H. Groen 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Pemetrexed and carboplatin, an active op

✍ Gervais, Radj; Robinet, Gilles; Clément-Duchêne, Christelle; Denis, Fabrice; Kou 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 303 KB